Feb 8 (Reuters)-
RaQualia Pharma Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 744 mln 1.42 2.02
(-47.5 pct) (+171.6 pct)
Operating loss 1.08 loss 150 mln 187 mln
Recurring loss 1.06 loss 80 mln 195 mln
Net
Net loss 1.10 loss 58 mln 153 mln
EPS loss 54.23 yen loss 2.99 yen 7.52 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - RaQualia Pharma Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T